Professional Summary
Professional Overview
Filippo Petti is a seasoned biopharmaceutical executive with over 20 years of experience in the industry. He currently serves as the Chief Executive Officer of Leucid Bio, where he leverages his deep expertise in oncology drug development, corporate strategy, and financial management to drive the company's growth and impact.
Experience Summary
Current Role
As the Chief Executive Officer of Leucid Bio, Petti is responsible for leading the company's strategic direction, overseeing research and development initiatives, and ensuring the successful execution of the company's business objectives. Under his leadership, Leucid Bio is poised to make significant advancements in the field of cellular immunotherapy.
Career Progression
Prior to his current role, Petti held several key positions at Celyad Oncology, including Executive Board Member, Chief Executive Officer, and Chief Financial Officer. In these roles, he was instrumental in shaping the company's corporate strategy, securing funding, and advancing the development of its novel cell therapy pipeline. Petti's earlier experience includes investment banking roles at Wells Fargo Securities and William Blair, where he provided strategic advisory services to biopharmaceutical companies.
Academic Background
Petti holds a Bachelor's degree in Chemistry from the University of Rochester and a Ph.D. in Biochemistry from the University of California, San Diego.
Areas of Expertise
- Oncology drug development
- Corporate strategy and business planning
- Financial management and capital markets
- Mergers, acquisitions, and strategic partnerships
- Team building and leadership
Professional Impact
Throughout his career, Petti has made significant contributions to the biopharmaceutical industry. He has played a pivotal role in securing funding, forging strategic partnerships, and advancing the development of innovative cancer therapies. His leadership and strategic vision have been instrumental in driving the growth and success of the organizations he has been a part of.
Conclusion
With his extensive experience, deep industry knowledge, and proven track record of success, Filippo Petti is well-positioned to lead Leucid Bio in its mission to develop transformative cellular immunotherapies that have the potential to improve the lives of cancer patients. His commitment to innovation and his ability to navigate the complex biopharmaceutical landscape make him a valuable asset to the company and the broader industry.
